Advanced Therapies 2021 | Developing manufacturing systems for cell and gene therapies

Kwok Pang, COO, Autolomous, London, UK, gives an overview of the work conducted at Autolomous, a software and technology provider for cell and gene therapy (CGT) developers. He describes ongoing UK government-supported projects including the development of a prototype IT system to streamline communications between the clinic and manufacturing processes to optimize the ordering of advanced therapy medicinal products by the UK NHS. He also describes the ongoing development of systems to help manage the high volume of data and regulatory information produced during the batch certification of cell therapies. This interview took place at the Advanced Therapies Congress & Expo 2021.